Evaluation of the effectiveness of a new drug Kurs Uspokoin tablets for the correction of age-related cognitive impairment in dogs

Abstract

The use of the drug Kurs Uspokoin tablets in a minimum initial daily dose of 7 mg/kg for the first three days, with a further increase in the minimum daily dose to 14 mg/kg, showed a positive effect in correcting the behavior of dogs older than 10 years with progressive signs of cognitive impairment.